Customers, suppliers, contractors, collaborators and other visitors of General Atomics and its Affiliates, please review our COVID-19 Visitor Information

News

Diazyme Expands Diabetic Portfolio with Beta-Hydroxybutyrate Assay

Mon, May 31, 2021
Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test

Tue, March 30, 2021
Diazyme Laboratories, Inc. Receives Reissued EUA for Semi-Quantitative SARS-CoV-2 IgG Test

Tue, March 23, 2021
Highlighted Study: SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses

Mon, March 15, 2021

News

Diazyme Expands Diabetic Portfolio with Beta-Hydroxybutyrate Assay

Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test

Diazyme Laboratories, Inc. Receives Reissued EUA for Semi-Quantitative SARS-CoV-2 IgG Test

Highlighted Study: SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses

Vitamin D Testing Simplified